Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor binding factor 2 pseudogene 1 (NRBF2P1) is categorized as a pseudogene in key gene databases[5]. Pseudogenes like NRBF2P1 are DNA sequences that resemble known genes (in this case, the functional NRBF2 gene), but typically lack protein coding ability due to disabling mutations, truncations, or the absence of essential regulatory elements[2][4]. NRBF2P1 is not known to encode a receptor, enzyme, transporter, or other functional protein; rather, it is a non-functional derivative of the NRBF2 locus. Although some pseudogenes have regulatory functions (such as miRNA decoy or modulation of gene expression), there is no direct evidence for NRBF2P1 having such a role, nor is it discussed as a therapeutic or diagnostic target in the literature provided[2][4][5]. As a result, NRBF2P1 is best considered a genomic locus of unknown physiological impact with no established clinical utility or relevance as a traditional pharmacological target. The gene is indexed with NCBI Gene accession 648532[5]. NRBF2P1 is named for its sequence similarity to nuclear receptor binding factor 2 (NRBF2), an autophagy-related and nuclear receptor coactivator protein, but does not exhibit functional activity itself[5][7]. Pseudogenes can sometimes play regulatory roles by acting as miRNA sponges or by influencing mRNA stability via competition for trans-acting elements, but this is not established for NRBF2P1 directly[2][4]. There is no evidence this pseudogene is expressed as a protein, nor that it directly impacts disease[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor binding factor 2 pseudogene 1 (NRBF2P1).